In utero treatment of severe fetal anemia resulting from fetomaternal red blood cell incompatibility: a comparison of simple transfusion and exchange transfusion

Author(s):  
Lucie Guilbaud ◽  
Charles Garabedian ◽  
Anne Cortey ◽  
Thameur Rakza ◽  
Bruno Carbonne ◽  
...  
2020 ◽  
Vol 77 (1) ◽  
pp. 8-13
Author(s):  
Mirjana Marjanovic-Cvjeticanin ◽  
Snezana Plesinac ◽  
Jelena Dotlic ◽  
Darko Plecas ◽  
Dusica Kocijancic-Belovic ◽  
...  

Background/Aim. Doppler sonography of fetal middle cerebral artery peak systolic velocity (MCA-PSV) can be used to predict fetal anemia and the need for in utero intravascular transfusion (IUIT) in red blood cell (RBC) alloimmunisation pregnancies. The aim of this study was to evaluate whether measurement of MCA-PSV in fetuses that had undergone one to three transfusions is a good diagnostic tool for fetal anemia. Methods. Study included 36 pregnancies treated due to RBC alloimmunisation in our tertiary referral center during the 5-year period (2012?2017). We measured MCA-PSV and hematocrit (Hct) in all patients. In seven pregnancies there was a need to perform sequential IUITs for correction of fetal anemia. In these patients we compared MCA-PSV and Hct values before and after every transfusion. Results. Hct and MCA-PSV correlated negatively before transfusion therapy (p = 0.035) and after the second transfusion (p = 0.046). Contrary, after the first (p = 0.954), before the second (p = 0.738), as well as before (p = 0.092) and after (p = 0,741) the third transfusions there were no significant correlations between Hct and MCAPSV values. Hct values before and after transfusions were positively associated (p = 0.001), but MCA-PSV were not (p = 0.296). According to performed receiver operating characteristic (ROC) analysis the cut-off point of MCA-PSV for investigated patients was 1.22 multiples of its median (MoM). Conclusion. There is a reduction in MCA-PSV accuracy for assessing fetal anemia in previously transfused fetuses. Larger studies are needed to explain the reasons for these findings and potentially set new referral values of MCA-PSV for better diagnostics of fetal anemia.


Author(s):  
Susanna A. Curtis ◽  
Balbuena-Merle Raisa ◽  
John D. Roberts ◽  
Jeanne E. Hendrickson ◽  
Joanna Starrels ◽  
...  

2001 ◽  
Vol 98 (3) ◽  
pp. 509-517 ◽  
Author(s):  
T. G. Divakaran ◽  
J. Waugh ◽  
T. J. Clark ◽  
K. S. Khan ◽  
M. J. Whittle ◽  
...  

2000 ◽  
Vol 320 (5) ◽  
pp. 337-341 ◽  
Author(s):  
Bina Tejura ◽  
David A. Sass ◽  
Robert A. Fischer ◽  
Glenn Eiger ◽  
Ierachmiel Daskal

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Baruch Abittan ◽  
Aaron Nizam ◽  
Michael Oey ◽  
Felicia Callan ◽  
Lisa Simmonds ◽  
...  

Babesiosis, caused predominantly by Babesia microti, is an emerging health risk in the Northeastern and Midwestern United States. We present a case of a pregnant woman with history of splenectomy diagnosed with babesiosis at 23 5/7 weeks of gestational age refractory to antimicrobial therapy. She underwent the first reported red blood cell exchange transfusion for babesiosis in pregnancy, at 24 4/7 weeks of gestational age, which resulted in resolution of parasitemia. She had a full term, uncomplicated cesarean delivery. Exchange transfusion is potentially a safe treatment option for severe babesiosis infection in pregnancy and should be considered when other methods are poorly tolerated or ineffective.


Sign in / Sign up

Export Citation Format

Share Document